I know next to nothing about oncology, but
- 11% average tumour reduction;
- in 2 weeks;
- at a significantly diluted dosage
- with a proven safety profile in animals (Zolvix)
It's not earth shattering news but it seemingly works (even at a low dose), in a timely manner, and is safe.
A bit harsh to say it's hard to get excited about imho. On the contrary, who isn't keen to see what tumour reduction is achievable with a full dose?
Ann: PharmAust Shareholders Update and Roadmap, page-20
Add NUZ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $93.42M | |||
| Open | High | Low | Value | Volume |
| 19.0¢ | 19.3¢ | 19.0¢ | $25.41K | 133.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5372 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.5¢ | 262575 | 3 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| NUZ (ASX) Chart |